Lymph flow augmentation secondary to increases in serum calcium.
D000315:Adrenalectomy; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000097:blood / Q000494:pharmacology*; D004285:Dogs; D008196:Lymph / Q000187:drug effects / Q000378:metabolism*; D010208:Papaverine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013390:Succinylcholine / Q000494:pharmacology; D013897:Thoracic Duct / Q000187:drug effects / Q000502:physiology*; D014403:Tubocurarine / Q000494:pharmacology
D010643:Phenoxybenzamine; D000804:Angiotensin II; D001285:Atropine; D012110:Reserpine; D011433:Propranolol; D010208:Papaverine; D013390:Succinylcholine; D002118:Calcium; D014403:Tubocurarine